EUROPEAN RESPIRATORY JOURNAL

Scope & Guideline

Leading Insights for Pulmonary Health

Introduction

Welcome to your portal for understanding EUROPEAN RESPIRATORY JOURNAL, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN0903-1936
PublisherEUROPEAN RESPIRATORY SOC JOURNALS LTD
Support Open AccessNo
CountrySwitzerland
TypeJournal
Convergefrom 1988 to 2024
AbbreviationEUR RESPIR J / Eur. Resp. J.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address442 GLOSSOP RD, SHEFFIELD S10 2PX, ENGLAND

Aims and Scopes

The European Respiratory Journal (ERJ) primarily focuses on advancing knowledge in respiratory medicine through high-quality research and clinical studies. Its scope encompasses a wide range of topics related to respiratory health, disease mechanisms, diagnostics, and therapeutic interventions.
  1. Pulmonary Disease Mechanisms:
    Research on the molecular and cellular mechanisms underlying various pulmonary diseases, including asthma, COPD, pulmonary fibrosis, and lung cancer.
  2. Clinical Guidelines and Practice:
    Development and dissemination of clinical practice guidelines for the management of respiratory conditions, ensuring evidence-based approaches in clinical settings.
  3. Innovative Therapies and Treatments:
    Exploration of novel therapeutic agents and treatment strategies, including biologics for severe asthma and personalized medicine approaches for chronic lung diseases.
  4. Epidemiology and Public Health:
    Studies focusing on the epidemiology of respiratory diseases, their risk factors, and public health implications, particularly in light of global health challenges such as the COVID-19 pandemic.
  5. Patient-Centered Research:
    Investigation of patient-reported outcomes, quality of life, and the psychosocial aspects of living with chronic respiratory diseases.
  6. Technological Advancements in Respiratory Medicine:
    Incorporation of innovative technologies, such as telemedicine and artificial intelligence, for improving patient care and outcomes in respiratory health.
The European Respiratory Journal has recently seen an increase in focus on several emerging themes that reflect the evolving landscape of respiratory medicine and public health.
  1. Long COVID and Post-Acute Sequelae:
    Research dedicated to understanding the long-term effects of COVID-19 on respiratory health, including pulmonary function and the management of post-COVID conditions.
  2. Personalized Medicine in Respiratory Care:
    A growing emphasis on tailoring treatments based on individual patient characteristics, particularly in managing chronic diseases like asthma and COPD.
  3. Artificial Intelligence and Digital Health:
    Emerging studies utilize artificial intelligence and digital health technologies to enhance diagnosis, treatment adherence, and patient monitoring in respiratory care.
  4. Environmental Impacts on Respiratory Health:
    Research exploring the effects of environmental factors, such as air pollution and occupational exposures, on respiratory diseases, emphasizing the need for public health interventions.
  5. Biologics and Targeted Therapies:
    Increased focus on the development and real-world application of biologics for severe asthma and other respiratory diseases, showcasing their effectiveness and safety in diverse populations.

Declining or Waning

While the European Respiratory Journal continues to cover a broad range of topics, certain areas of research appear to be declining in prominence based on recent publications.
  1. Traditional Pharmacotherapy:
    There is a noticeable shift towards biologics and targeted therapies, leading to less focus on traditional pharmacotherapy approaches, such as corticosteroids and bronchodilators.
  2. Basic Science Studies:
    Although foundational research remains important, there has been a growing preference for translational and clinical studies that directly impact patient care over purely basic science investigations.
  3. Epidemiological Studies in Stable Populations:
    Research focusing on stable populations without chronic diseases is becoming less frequent, with a pivot towards studies addressing exacerbations, long-term outcomes, and complications in chronic respiratory conditions.

Similar Journals

Tuberculosis and Respiratory Diseases

Exploring the frontiers of respiratory disease management.
Publisher: THE KOREAN ACAD TUBERCULOSIS & RESPIRATORY DISEASESISSN: 1738-3536Frequency: 4 issues/year

Tuberculosis and Respiratory Diseases is a leading open-access journal published by THE KOREAN ACADEMY OF TUBERCULOSIS & RESPIRATORY DISEASES, dedicated to disseminating knowledge in the fields of infectious diseases and pulmonary medicine. Since its inception in 1980, the journal has undergone significant growth, currently recognized in the elite Q2 category for both Infectious Diseases and Pulmonary and Respiratory Medicine as of 2023. With an impact factor reflecting its esteemed position—ranked 52nd in its category—it serves as a vital resource for researchers and healthcare professionals seeking cutting-edge insights, studies, and advancements in the management and treatment of respiratory diseases, particularly tuberculosis. The journal is committed to providing open access to its content since 2013, ensuring that critical research is available to scholars worldwide, fostering collaboration and innovation in the global fight against respiratory illnesses.

Clinical Medicine Insights-Circulatory Respiratory and Pulmonary Medicine

Exploring the Frontiers of Cardiology and Pulmonology
Publisher: SAGE PUBLICATIONS LTDISSN: 1179-5484Frequency: 1 issue/year

Clinical Medicine Insights-Circulatory Respiratory and Pulmonary Medicine, published by SAGE Publications Ltd, stands as a vital resource in the fields of Cardiology and Pulmonary Medicine, underscored by its Q3 quartile rankings in both areas for 2023. Established in 2007 as an open-access journal, it facilitates the dissemination of cutting-edge research and observations from the international scientific community. With an ISSN of 1179-5484, the journal has garnered recognition for its contributions to clinical medicine, particularly covering topics of circulatory, respiratory, and pulmonary health. The journal not only aims to bridge the gap between research and clinical practice but also to serve as a platform for innovative ideas and collaborations among researchers, healthcare professionals, and trainees. By offering unrestricted access to its articles, Clinical Medicine Insights ensures that vital knowledge reaches a broad audience, ultimately fostering advancements in medical science and patient care.

Respiratory Investigation

Shaping tomorrow's respiratory practices today.
Publisher: ELSEVIERISSN: 2212-5345Frequency: 6 issues/year

Respiratory Investigation is a leading peer-reviewed journal published by Elsevier, dedicated to advancing the field of Pulmonary and Respiratory Medicine. Since its inception in 2012, the journal has grown to become a vital resource for researchers, clinicians, and students alike, providing a platform for high-quality research articles, reviews, and clinical studies. With a commendable impact factor and ranked in the Q2 category of Scopus' 2023 metrics, it stands at rank #57 out of 155 in its field, illustrating its importance and influence within the academic community. Although the journal operates on a subscription basis, it remains committed to disseminating essential findings that enhance the understanding and treatment of respiratory diseases. Set against the innovative backdrop of the Netherlands, Respiratory Investigation not only serves as a conduit for scholarly exchange but also plays a critical role in shaping future research directions and clinical practices.

RESPIROLOGY

Championing Collaborative Research in Respirology
Publisher: WILEYISSN: 1323-7799Frequency: 12 issues/year

RESPIROLOGY is a prestigious academic journal that focuses on the field of Pulmonary and Respiratory Medicine, publishing high-quality research and comprehensive reviews that contribute significantly to the understanding and management of respiratory health. As a distinguished publication of WILEY, it has established a strong presence in the academic world with an impressive impact factor and ranked in the Q1 category, recognized for its influence and innovation in the field. RESPIROLOGY is committed to disseminating cutting-edge research from 1996 through 2024, appearing regularly in SCOPUS with a rank of #14 out of 155, placing it in the rarefied 91st percentile among its peers. The journal invites contributions from researchers, professionals, and students, fostering a collaborative space for advancing knowledge in pulmonary medicine. Although it does not offer open access, its readership spans globally, indicating the high regard in which it is held within the scientific community.

Jornal Brasileiro de Pneumologia

Connecting researchers for a healthier tomorrow in respiratory care.
Publisher: SOC BRASILEIRA PNEUMOLOGIA TISIOLOGIAISSN: 1806-3713Frequency: 6 issues/year

Jornal Brasileiro de Pneumologia is a pivotal open-access journal in the field of Pulmonary and Respiratory Medicine, published by SOC BRASILEIRA PNEUMOLOGIA TISIOLOGIA. Established in 2004, this esteemed publication has become a significant platform for researchers, health professionals, and students in Brazil and beyond, facilitating the exchange of innovative ideas and vital research findings. The journal is indexed in Scopus and is recognized in the 2023 category quartiles as Q3, ranking 86 out of 155 in its field with a corresponding 44th percentile. This reflects its growing influence and commitment to advancing knowledge concerning respiratory health. With a mission to disseminate high-quality research, the journal aims to foster advancements in clinical practice and improve outcomes in pulmonary diseases, making it an essential resource for those dedicated to enhancing the quality of care in respiratory medicine. For those seeking comprehensive access to critical studies and reviews in this domain, the Jornal Brasileiro de Pneumologia remains an invaluable asset.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Transforming critical care practices with peer-reviewed excellence.
Publisher: AMER THORACIC SOCISSN: 1073-449XFrequency: 24 issues/year

American Journal of Respiratory and Critical Care Medicine, published by the American Thoracic Society, is a leading scholarly journal dedicated to advancing the fields of critical care and pulmonary medicine. With an impressive impact factor and recognized in the Q1 quartile for both Critical Care and Pulmonary Medicine, this journal is essential reading for researchers, clinicians, and students invested in innovative practices and therapies in respiratory health. Through high-quality, peer-reviewed research articles, the journal addresses significant contemporary issues in respiratory and critical care, offering unparalleled insights and fostering interdisciplinary collaboration. Although the journal adheres to a traditional subscription model, it remains a cornerstone for those wishing to stay at the forefront of medical science in this vital area. With its extensive historical context since its establishment in 1991 and continuous publication spanning through 2024, the journal is committed to promoting discourse and disseminating knowledge that ultimately enhances patient care and clinical outcomes.

Canadian Journal of Respiratory Critical Care and Sleep Medicine

Fostering collaboration for groundbreaking medical insights.
Publisher: TAYLOR & FRANCIS INCISSN: 2474-5332Frequency: 4 issues/year

Welcome to the Canadian Journal of Respiratory Critical Care and Sleep Medicine, a prestigious peer-reviewed journal published by Taylor & Francis Inc. With an ISSN of 2474-5332 and an E-ISSN of 2474-5340, this journal serves as a vital platform for disseminating cutting-edge research in the fields of critical care, intensive care medicine, and pulmonary and respiratory medicine. Since its inception in 2017, the journal has established itself within the academic community, currently holding a Q2 ranking in Critical Care and Intensive Care Medicine and a Q3 ranking in Pulmonary and Respiratory Medicine for 2023. Although it operates under a standard access model, the journal remains committed to providing valuable insights and advancing knowledge through rigorous research articles, reviews, and case studies. Positioned in the heart of the United States, the journal aims to foster collaboration and innovation among healthcare professionals, researchers, and students dedicated to enhancing respiratory care and critical treatment protocols. Join us in exploring the dynamic intersection of research and practice that defines our mission.

REVUE DES MALADIES RESPIRATOIRES

Fostering discussions that shape respiratory care.
Publisher: MASSON EDITEURISSN: 0761-8425Frequency: 10 issues/year

REVUE DES MALADIES RESPIRATOIRES is a distinguished journal published by MASSON EDITEUR, focusing on the vital field of pulmonary and respiratory medicine. Established in 1984, this journal has become a prominent platform for sharing innovative research and clinical findings, reflecting an impressive array of studies that contribute to our understanding of respiratory diseases. With its ISSN 0761-8425 and E-ISSN 1776-2588, it facilitates access to scholarly work within the medical community, although it currently operates under a subscription model rather than Open Access. As indicated by its quartile ranking of Q4 in 2023 within its category and a Scopus rank of #128/155, REVUE DES MALADIES RESPIRATOIRES serves as an essential resource for researchers, professionals, and students aiming to stay informed about advancements in respiratory health. This journal plays a crucial role in fostering discussions that drive innovation and best practices in the treatment and understanding of respiratory conditions.

Egyptian Journal of Chest Diseases and Tuberculosis

Innovative insights for combating respiratory challenges.
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 0422-7638Frequency: 4 issues/year

The Egyptian Journal of Chest Diseases and Tuberculosis is a premier Open Access journal published by Wolters Kluwer Medknow Publications, focusing on the latest advancements in the fields of respiratory diseases, pulmonary medicine, and tuberculosis management. With an ISSN of 0422-7638 and an E-ISSN of 2090-9950, this journal aims to disseminate high-quality research, reviews, and clinical insights that advance the understanding and treatment of chest diseases. Since its transition to Open Access in 2018, the journal has garnered increased visibility, enabling researchers across the globe to contribute and access valuable content without barriers. Situated in India, the journal is dedicated to bridging the gap between clinical practice and research, emphasizing the significance of innovative therapeutic strategies and public health approaches in combating respiratory illnesses. We invite researchers, healthcare professionals, and students to engage with our publications as we continue to foster knowledge and foster collaboration within the global medical community.

Thoracic Research and Practice

Pioneering Discoveries in Pulmonary and Respiratory Medicine
Publisher: AVESISSN: Frequency: 6 issues/year

Thoracic Research and Practice is an emerging open access journal published by AVES that aims to advance knowledge in the field of pulmonary and respiratory medicine. Launched in 2022, this journal aspires to provide a platform for innovative research, clinical practices, and advancements in thoracic health. With an E-ISSN of 2979-9139, it caters to a global audience while based in Turkey. Although it currently holds a Q4 category in the 2023 ranking within its field, the journal is dedicated to improving its standing through the inclusion of high-quality, original articles, systematic reviews, and case studies. As it converges years from 2023 to 2024, Thoracic Research and Practice invites researchers, professionals, and students to contribute valuable insights that aim to enhance patient outcomes and propel further exploration in this critical area of medicine.